Abdul-Ghani M - Search Results

1

Predicting long-term type 2 diabetes with support vector machine using oral glucose tolerance test.

Abbas HT, Alic L, Erraguntla M, Ji JX, Abdul-Ghani M, Abbasi QH, Qaraqe MK. Abbas HT, et al. PLoS One. 2019 Dec 11;14(12):e0219636. doi: 10.1371/journal.pone.0219636. eCollection 2019. PLoS One. 2019. PMID: 31826018 Free PMC article.

2

Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test.

Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA. Abdul-Ghani MA, et al. Diabetes Care. 2007 Jan;30(1):89-94. doi: 10.2337/dc06-1519. Diabetes Care. 2007. PMID: 17192339

3

What is the best predictor of future type 2 diabetes?

Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. Abdul-Ghani MA, et al. Diabetes Care. 2007 Jun;30(6):1544-8. doi: 10.2337/dc06-1331. Epub 2007 Mar 23. Diabetes Care. 2007. PMID: 17384342

4

Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range.

Jani R, Molina M, Matsuda M, Balas B, Chavez A, DeFronzo RA, Abdul-Ghani M. Jani R, et al. Diabetes Care. 2008 Feb;31(2):311-5. doi: 10.2337/dc07-1593. Epub 2007 Nov 13. Diabetes Care. 2008. PMID: 18000182

5

One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes.

Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA. Abdul-Ghani MA, et al. Diabetes Care. 2008 Aug;31(8):1650-5. doi: 10.2337/dc08-0225. Epub 2008 May 16. Diabetes Care. 2008. PMID: 18487478 Free PMC article.

6

Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study.

Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L. Abdul-Ghani MA, et al. Diabetes Care. 2009 Feb;32(2):281-6. doi: 10.2337/dc08-1264. Epub 2008 Nov 18. Diabetes Care. 2009. PMID: 19017778 Free PMC article.

7

Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.

Chavez AO, Molina-Carrion M, Abdul-Ghani MA, Folli F, Defronzo RA, Tripathy D. Chavez AO, et al. Diabetes Care. 2009 Aug;32(8):1542-6. doi: 10.2337/dc09-0684. Epub 2009 Jun 1. Diabetes Care. 2009. PMID: 19487637 Free PMC article.

8

Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucose.

Abdul-Ghani MA, Stern MP, Lyssenko V, Tuomi T, Groop L, Defronzo RA. Abdul-Ghani MA, et al. Diabetes Care. 2010 Mar;33(3):557-61. doi: 10.2337/dc09-1145. Epub 2009 Dec 10. Diabetes Care. 2010. PMID: 20007945 Free PMC article.

9

Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.

Kanat M, Norton L, Winnier D, Jenkinson C, DeFronzo RA, Abdul-Ghani MA. Kanat M, et al. Acta Diabetol. 2011 Sep;48(3):209-17. doi: 10.1007/s00592-011-0285-x. Epub 2011 May 8. Acta Diabetol. 2011. PMID: 21553243 Clinical Trial.

10

Distinct β-cell defects in impaired fasting glucose and impaired glucose tolerance.

Kanat M, Mari A, Norton L, Winnier D, DeFronzo RA, Jenkinson C, Abdul-Ghani MA. Kanat M, et al. Diabetes. 2012 Feb;61(2):447-53. doi: 10.2337/db11-0995. Diabetes. 2012. PMID: 22275086 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters